<?xml version="1.0" encoding="UTF-8"?>
<ref id="B99-biomedicines-08-00109">
 <label>99.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tan</surname>
    <given-names>E.L.C.</given-names>
   </name>
   <name>
    <surname>Eong Ooi</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>C.-Y.</given-names>
   </name>
   <name>
    <surname>Cheng Tan</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Ling</surname>
    <given-names>A.E.</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Stanton</surname>
    <given-names>L.W.</given-names>
   </name>
  </person-group>
  <article-title>Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Drugs</article-title>
  <source>Emerg. Inf. Dis.</source>
  <year>2004</year>
  <volume>10</volume>
  <fpage>581</fpage>
  <lpage>586</lpage>
  <pub-id pub-id-type="doi">10.3201/eid1004.030458</pub-id>
 </element-citation>
</ref>
